Entheon Biomedical Financials
| ENTBF Stock | USD 0.12 0.04 60.00% |
With this module, you can analyze Entheon financials for your investing period. You should be able to track the changes in Entheon Biomedical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Entheon |
Understanding current and past Entheon Biomedical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Entheon Biomedical's financial statements are interrelated, with each one affecting the others. For example, an increase in Entheon Biomedical's assets may result in an increase in income on the income statement.
The data published in Entheon Biomedical's official financial statements typically reflect Entheon Biomedical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Entheon Biomedical's quantitative information. For example, before you start analyzing numbers published by Entheon accountants, it's essential to understand Entheon Biomedical's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Entheon Biomedical Stock Summary
Entheon Biomedical competes with Dave Busters, Allient, Ebang International, Vishay Precision, and Asure Software. Entheon Biomedical Corp. operates as a biotechnology research and drug development company. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. ENTHEON BIOMEDICAL operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| Business Address | 999 West Broadway, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.entheonbiomedical.com |
| Phone | 604 562 3932 |
| Currency | USD - US Dollar |
Entheon Biomedical Key Financial Ratios
There are many critical financial ratios that Entheon Biomedical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Entheon Biomedical Corp reports annually and quarterly.| Return On Equity | -0.55 | |||
| Return On Asset | -0.46 | |||
| Beta | 1.89 | |||
| Z Score | 2.4 |
Entheon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entheon Biomedical's current stock value. Our valuation model uses many indicators to compare Entheon Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entheon Biomedical competition to find correlations between indicators driving Entheon Biomedical's intrinsic value. More Info.Entheon Biomedical Corp is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Entheon Biomedical's earnings, one of the primary drivers of an investment's value.Entheon Biomedical Corp Systematic Risk
Entheon Biomedical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Entheon Biomedical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Entheon Biomedical Corp correlated with the market. If Beta is less than 0 Entheon Biomedical generally moves in the opposite direction as compared to the market. If Entheon Biomedical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Entheon Biomedical Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Entheon Biomedical is generally in the same direction as the market. If Beta > 1 Entheon Biomedical moves generally in the same direction as, but more than the movement of the benchmark.
Entheon Biomedical March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Entheon Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Entheon Biomedical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Entheon Biomedical Corp based on widely used predictive technical indicators. In general, we focus on analyzing Entheon OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Entheon Biomedical's daily price indicators and compare them against related drivers.
| Downside Deviation | 21.01 | |||
| Information Ratio | 0.0967 | |||
| Maximum Drawdown | 170.83 | |||
| Value At Risk | (23.53) | |||
| Potential Upside | 60.0 |
Complementary Tools for Entheon OTC Stock analysis
When running Entheon Biomedical's price analysis, check to measure Entheon Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entheon Biomedical is operating at the current time. Most of Entheon Biomedical's value examination focuses on studying past and present price action to predict the probability of Entheon Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entheon Biomedical's price. Additionally, you may evaluate how the addition of Entheon Biomedical to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |